Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Ede Ronald Hao Xi, Executive. Insider active across 1 company, notably Innovent Biologics, Inc.. Aggregated, 7 disclosures have been recorded. History available since 30 March 2026. The latest transaction was filed on 6 July 2026 (Sale). Regulator: HKEX. All data is accessible without signup.
7 of 7 declarations
Ede Ronald Hao Xi is an executive at Innovent Biologics, Inc. He is involved in managing the company's operations, which focuses on developing biological drugs. Ede Ronald Hao Xi is responsible for formulating business strategies and optimizing operations to ensure customer satisfaction and profitability. His expertise is essential for navigating a competitive market.